JPH0323868A - Percataneous terminal - Google Patents
Percataneous terminalInfo
- Publication number
- JPH0323868A JPH0323868A JP1157152A JP15715289A JPH0323868A JP H0323868 A JPH0323868 A JP H0323868A JP 1157152 A JP1157152 A JP 1157152A JP 15715289 A JP15715289 A JP 15715289A JP H0323868 A JPH0323868 A JP H0323868A
- Authority
- JP
- Japan
- Prior art keywords
- terminal
- epidermal tissue
- living body
- external force
- fixing member
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013013 elastic material Substances 0.000 claims abstract description 6
- 210000001519 tissue Anatomy 0.000 claims description 27
- 229910010293 ceramic material Inorganic materials 0.000 claims description 16
- 206010033675 panniculitis Diseases 0.000 claims description 13
- 210000004304 subcutaneous tissue Anatomy 0.000 claims description 13
- 230000000694 effects Effects 0.000 abstract description 10
- 230000006378 damage Effects 0.000 abstract description 9
- 230000002411 adverse Effects 0.000 abstract description 8
- 229920002379 silicone rubber Polymers 0.000 abstract description 4
- 239000004945 silicone rubber Substances 0.000 abstract description 4
- 238000007920 subcutaneous administration Methods 0.000 description 19
- 239000000463 material Substances 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 9
- 241000283690 Bos taurus Species 0.000 description 6
- 239000000919 ceramic Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 229930182556 Polyacetal Natural products 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229920001973 fluoroelastomer Polymers 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920006324 polyoxymethylene Polymers 0.000 description 2
- 229920003225 polyurethane elastomer Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000005312 bioglass Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
[産梨上の利用分Jlji′−コ
本発明は、例えば血圧、血流の速度″0.lJの生体情
報を取り出すため、あるいは輸血や輸iffl等の注入
口として、または血液や体液等の採取目として、さらに
は生体内に設けられた人口臓器等に信号や電力を供給す
るために生体の内外境界に定置される経皮端子に関する
。[Detailed Description of the Invention] [Utilization of the present invention is for extracting biological information such as blood pressure and blood flow rate of 0.1J, or as an inlet for blood transfusion, transfusion, etc. The present invention relates to a percutaneous terminal that is placed at the internal and external boundaries of a living body to collect blood, body fluids, etc., or to supply signals and power to artificial organs installed in the living body.
[従来の技術]
この種の経皮端子としては、例えば特開昭5 9 −
1. 4 6 6 6 2号公報、または特開昭609
2768号公報=5において知られている。[Prior Art] As this type of percutaneous terminal, for example, Japanese Patent Application Laid-Open No. 1983-1999
1. Publication No. 4 6 6 6 2 or JP-A-609
It is known from Japanese Patent No. 2768=5.
また、経皮端子は、生体の内外堝界に定置させて生体内
外を連通させるが、その生体内外を連通させる部1立か
らの感染を防止する目的で、経皮端子本体を生体内外部
分に密着させる必要がある。In addition, percutaneous terminals are placed between the inside and outside of a living body to communicate between the inside and outside of the living body, but in order to prevent infection from the part that communicates between the inside and outside of the living body, the percutaneous terminal body is placed between the inside and outside of the living body. It needs to be in close contact.
このため、経皮端了本体をβ−TCP (β−リン酸三
カルシウム)、ハイトロキンアパタイト、バイオガラス
′.5、生体組織にNM aまたは密着する性質を有す
る生体適合性セラミックス月料にて形成する。For this reason, the main body of the transdermal treatment is β-TCP (β-tricalcium phosphate), hytroquine apatite, bioglass. 5. Made of NMa or a biocompatible ceramic material that has the property of adhering closely to living tissue.
また、特願昭62−2961 63号出願の経皮端子で
は、セラミックスH}.:1でなる本体の外表面に、コ
ラーゲンを付着して{114成し、表皮#ll織と経皮
端子との結合または密着する特性を高め、その接合部位
からの細菌の感染を防1トずるようにしている。In addition, in the percutaneous terminal of Japanese Patent Application No. 1962-2961 63, ceramics H}. : Collagen is attached to the outer surface of the main body consisting of {114} to enhance the bonding or close contact between the epidermal tissue and the percutaneous terminal, and prevent bacterial infection from the joint site. I'm trying to cheat.
[発明が財決しようとする課釘]
しかしなから、’dft来の経皮端了における端了本体
は、いずれもセラミックス材料で形J戊されている。セ
ラミソクス材料は脆性+−1料てあり、映<もろいす生
質を自゛している。[The section on which the invention is trying to settle the bill] However, the main bodies of the transdermal terminals since 'DFT have all been made of ceramic material. The ceramic material is a brittle +-1 material and has a film-like property.
したかって、経皮端−r−に物か当たったりして外力か
加えられると、その経皮端子か破損する虞れかあった。Therefore, if an object hits the percutaneous end -r- and an external force is applied, there is a risk that the percutaneous terminal will be damaged.
経皮端子か破損すると、皮下組織にj八一影響を与える
不具合を!1−シる。If the percutaneous terminal is damaged, the subcutaneous tissue will be affected! 1-Shiru.
また、経皮端子か破損しなくても、その経皮端子本体に
使用しているセラミックスH 料は硬いため、経皮端子
に加わった外力か吸収されずに直接、皮下組織に加えら
れることとなり、皮下組織に悪影響を与えることかBえ
られる。Furthermore, even if the percutaneous terminal does not break, the ceramic H material used in the percutaneous terminal body is hard, so any external force applied to the percutaneous terminal will not be absorbed and will be applied directly to the subcutaneous tissue. It is believed that it may have an adverse effect on the subcutaneous tissue.
本発明は上記課題に着[1してなされたもので、その目
的とするところは、外力が加わった際に破損したり、皮
下ill織に悪影響を!Jえる虞れの少ない経皮端子を
捉供ずることにある。The present invention has been made to solve the above problem, and its purpose is to prevent damage or adverse effects on the subcutaneous tissue when external force is applied. The purpose of the present invention is to provide a percutaneous terminal with less risk of injury.
?課題を舶″決する手段および作用]
上記課西をW(決するために本発明は、牛体の表皮組織
を経て、端子本体の一部を体外に突出させた形で生体内
に埋込み留置される経皮端子において、この端子木体は
、少なくとも生体の表皮組織と接合する接合部分を生体
適合性セラミックス月料で形成し、上記表皮組織との接
合する部位以外で、ノ1:体内に埋め込み留置される部
分に皮下組織に当たる而状部を設け、上記面状部、また
はその面状部と上記接合部分との間を連結する部分の少
なくとも一方を弾性材料にて形成したものである。? Means and Effects for Solving the Problems] In order to solve the above problem, the present invention provides a method for implanting and indwelling a terminal in a living body through the epidermal tissue of a cow, with a part of the terminal body protruding outside the body. In the percutaneous terminal, the terminal body is made of biocompatible ceramic material at least at the joint part that joins with the epidermal tissue of the living body, and is implanted in the body at least at the part where it joins with the epidermal tissue. At least one of the planar portion or a portion connecting the planar portion and the joint portion is formed of an elastic material.
一般に、外力が加イつることによる経皮端子の破損や、
生体組織の悪影響を防止するためには、釧力を吸収しう
るツ111性材料によって経皮端子を構或することか効
果的である。In general, damage to the percutaneous terminal due to external force,
In order to prevent adverse effects on living tissue, it is effective to construct the percutaneous terminal with a material that can absorb the clamping force.
しかし、経皮端子を■L体組織に密るさせて、感染をl
jJj +lするためには経皮端子を牛体と直接に粘合
または密着する性質を有する生体適合性セラミッ伺料で
{み1成することか必要である。ここで、細閏等による
感染は、皮膚、特に表皮組織と経皮端子との桔合か不十
分である際に、表皮組織と経皮端子の接触部位より、細
菌等か皮ドに侵入して引き起こされるものであるから、
表皮組織と皮ド端子の接触部位は細菌の侵入を防止する
ために生体と直接に粘介または密石ずる性質を(−j゛
ずるノ1体適合性セラミックス月料で横成する必要があ
る。However, by placing the percutaneous terminal close to body tissue, infection can be prevented.
In order to achieve this, it is necessary to coat the percutaneous terminal with a biocompatible ceramic material that has the property of adhering or adhering directly to the cow's body. Infection caused by small needles, etc. occurs when bacteria and the like invade the skin through the contact area between the epidermal tissue and the percutaneous terminal when the skin, especially the epidermal tissue, and the percutaneous terminal are insufficiently bonded. Because it is caused by
In order to prevent the invasion of bacteria, the contact area between the epidermal tissue and the skin contact area must be made of a ceramic material that is compatible with the living body and has a viscous or microscopic property. .
ところで、」二記表皮組織と経皮端子との接触部位以外
の部位、例えば皮下埋め込み部位は、生体親和性材料で
あれば、生体と直接桔合しなくともよい。本発明は、こ
の点に注目してなされたちのであり、表皮組織との接触
する部位を、生体と直接に桔合する性質をHする生体適
合性セラミックス材料で構戊するとともに、表皮組織と
の接触しない部位の少なくとも一部を外力を吸収する弾
性伺料にて構或した。By the way, the area other than the contact area between the epidermal tissue and the percutaneous terminal, for example, the subcutaneous implantation area, does not need to be directly connected to the living body if it is made of a biocompatible material. The present invention has been made with this point in mind, and the part that comes into contact with the epidermal tissue is made of a biocompatible ceramic material that has the property of directly interfacing with the living body. At least a portion of the non-contact area is made of an elastic material that absorbs external force.
[夷施例]
第1図および第2閣は木発明の第1の丈施例を示すもの
である。この丈施例の皮下端子1における端子本体1a
は略円筒状の連通部+A2と、こ5
の連通部月2の下部外周に被嵌して設けられた円板状の
固定部伺3とよりなる。[Embodiment] Figures 1 and 2 show the first embodiment of the wooden invention. Terminal body 1a in subcutaneous terminal 1 of this length example
5 consists of a substantially cylindrical communicating portion +A2 and a disk-shaped fixing portion 3 fitted over the lower outer periphery of the communicating portion 2.
連通部伺2は、β−TCP (リン酸三カルンウム)、
リン酸四カルシウム、ハイドロキンアパタイト、ハイオ
ガラス等、生体と直接に結合する性質を有する生体適合
性セラミックス材料にて形戊されている。連通部利2の
略中央部には、リード線、カテ−テル等を通すための連
通孔4が設けられている。The communication part 2 is made of β-TCP (tricarunium phosphate),
It is made of biocompatible ceramic materials such as tetracalcium phosphate, hydroquinapatite, and hyoglas, which have the property of directly bonding with living organisms. A communication hole 4 for passing lead wires, catheters, etc. is provided approximately at the center of the communication portion 2. As shown in FIG.
また、固定部伺3は、シリコンゴム、ポリウレタンエラ
スl・マ、フッ素ゴム、ポリエチレン、ポリアセタ−ル
等の生体適合性を有する弾性利料にて円板形状に形成さ
れている。この固定部月3の中央部分には」二記連通部
月2の外周に形成した周回溝5に彼嵌する孔部6か形成
されている。また、固定部材3の外周部近傍には、後述
する生体7の皮下組織7aに縫合固定するとぎに縫合糸
8を通すための複数の小孔9か設けられている。Further, the fixing part support 3 is formed into a disk shape using a biocompatible elastic material such as silicone rubber, polyurethane elastomer, fluororubber, polyethylene, or polyacetal. A hole 6 is formed in the center of the fixed part 3 to fit into a circumferential groove 5 formed on the outer periphery of the second communicating part 2. Further, near the outer periphery of the fixing member 3, a plurality of small holes 9 are provided through which the suture thread 8 is passed when sutured and fixed to the subcutaneous tissue 7a of the living body 7, which will be described later.
第2図はこの皮下端子コを生体7に取り付けた使用状態
を示している。皮下端T−1は、表皮相織6
?bに接合する連通部月2の一部を生体7の表皮組#W
7bから突き出ず形で、皮ドに埋め辻J二れる。FIG. 2 shows the state in which this subcutaneous terminal is attached to a living body 7. The subcutaneous end T-1 is the epidermis layer 6? Part of the communicating part 2 that joins b is attached to the epidermis #W of the living body 7.
It does not protrude from 7b, but is buried in the skin.
囚定部月13の下1如は皮下組織7aに゛−1て1:)
れる。The lower part of the prisoner part month 13 is in the subcutaneous tissue 7a ゛-1te 1:)
It will be done.
そして、これに設けられた小孔9に1′連合糸8を通し
てり皮下組i7ai.:fin合固定される。つまり、
」二記固疋部刊3は皮下組織7aに当たる而臥部十4を
+,!77 l戊している。Then, thread the 1' combination thread 8 through the small hole 9 provided in the subcutaneous assembly i7ai. : Fin match is fixed. In other words,
''2kikokubukan 3 +,! 77 I'm exhausted.
また、この坦l説払態において、連通部+12の連通孔
4には、り−1一線、カテーテル等の1lrl通部イ」
、例えばり−1・線10か、気密、肢倖1な状態て接■
jされている。つまり、り−1・線]口なとの連通部例
を使用して、生体7の内外を連通ずることかできる。In addition, in this flattened state, the communication hole 4 of the communication part +12 has a line 1 and a line 11 for a catheter, etc.
, for example, if the wire is 10 or wire 10, it should be connected in an airtight, 1-wire condition.
j has been done. In other words, the inside and outside of the living body 7 can be communicated by using the example of the communication part with the line 1 and the mouth.
ところで、上記連通部月2は、/−1:.体7と直接に
結合するセラミックス制料で形威されているため、その
突出部において表皮組織7aと確丈に密着し、この部分
から細閏なとの侵入を防ぎ、感染を防止することかでき
る。By the way, the communication department month 2 is /-1:. Since it is made of ceramic material that is directly bonded to the body 7, its protruding portion tightly adheres to the epidermal tissue 7a, preventing small particles from entering from this portion and preventing infection. can.
また、上記固足部月3は、シリコンゴム″.9のツ1i
+性伺料にて形成されているため、経皮端子]に物を当
てたり帝引したりする等による外力か加わった場合、そ
の外力をそれ白身の弥性により吸収してしまい経皮端子
]か破損したり、皮下組織7aに大きな衝撃を与えて生
体7に悪い影響を与える虞れか少なくなる。In addition, the solid foot part 3 is made of silicone rubber ".9".
Since the transdermal terminal is made of a transparent material, if an external force is applied to the transdermal terminal, such as by hitting an object or pulling it, the external force will be absorbed by the material of the transdermal terminal. ], the risk of damage or giving a large impact to the subcutaneous tissue 7a and adversely affecting the living body 7 is reduced.
上記47,y成によれば、感染の危険を「111避しな
から、外力による皮下端了]の破損を防止することかで
きるとともに、外力か生体組織へljえる悪影響などの
不具合を角4′哨する。According to the above-mentioned article 47, y, it is possible to reduce the risk of infection and prevent damage to the subcutaneous tissue due to external forces, as well as to prevent problems such as the negative effects of external forces on living tissue. 'To watch.
なお、」一記固定部月3はその外周面に生体適合住4A
料をコーティングした物でもよい。さらに、固定部月3
を、第3図で示すように映質伺料部分3aと弥性+1料
部分3bとを例えばその円周上において等間隔に交−1
1に配設するように設けるようにしたものでもよい。In addition, the fixed part 3 has a biocompatible housing 4A on its outer peripheral surface.
It may also be coated with a material. In addition, fixed part month 3
As shown in FIG.
It may be arranged such that it is disposed at 1.
第4図は本允明の第2の実施例を示すものである。この
実地例の皮下端子1]の端子本体1 1 aは、上記連
通部4イ2と固定部伺3に相当する部分を、シリコンゴ
ム、ポリウレタンエラス1・マ、フッ素ゴム、ポリエチ
レン、ポリアセタール等の生体適合性を有する弥性伺料
より一体とに描成してなり、さらに端子本体11aの上
部、つまり生体7に留置したとき、皮膚から突出する部
位の外周には略円筒状の接合部月13か、気密、液密的
に1妾るl司定して1皮石している。この1妾へ部+4
13の伺料どしては、β一TCPSl\イl・ロギンア
パタイ1・、ハイオガラス;9の牛体7と直接に桔へす
る性質を右する牛体適合性セラミソクス材料にて形成さ
れている。なお、この端子本体1 1. aにち、連通
孔14や小孔15かそれそれ設けられている。FIG. 4 shows Masaaki Moto's second embodiment. The terminal body 11a of the subcutaneous terminal 1 in this practical example has the parts corresponding to the communicating part 4i2 and the fixing part 3 made of silicone rubber, polyurethane elastomer, fluoro rubber, polyethylene, polyacetal, etc. The terminal body 11a has a substantially cylindrical joint on the upper part of the terminal body 11a, that is, on the outer periphery of the part that protrudes from the skin when it is placed in the living body 7. 13 years old, it is air-tight and liquid-tight to control one concubine and one skin stone. To this one concubine +4
The material 13 is made of a ceramic material compatible with the cow body 7, which has the property of being directly attached to the cow body 7 of β-TCPS1\Il Login Apatite 1. In addition, this terminal body 1 1. At step a, communicating holes 14 and small holes 15 are provided.
そして、この経皮端子1]は、朶4図で示すように接合
部刊13の一部を表皮組fa 7 bから体外に突出す
る形で皮下に埋め込み留置され、小孔]5を使川し、縫
合糸18によって皮下組gQ7aに縫合固定する。なお
、連通孔]4には、その使用目的に応じて、カテーテル
、リード線″.+1゛を取りイ・1けることかてきる。As shown in Figure 4, this percutaneous terminal 1 is implanted under the skin with a part of the junction 13 protruding outside the body from the epidermis fa7b, and the small hole 5 is inserted into the body. Then, it is sutured and fixed to the subcutaneous braid gQ7a using suture thread 18. In addition, a catheter and a lead wire ".+1" can be inserted into the communication hole 4 depending on the purpose of use.
また、接合部月13は、生体と直接に桔合するセラミッ
クス+イ料で形成されているため、表皮組織7bと直接
に結合することにより、細菌等の侵9
人を防ぎ、感染を防止する。端子木体11aはツリi性
材料にて形成されているため、物をぶつける、牽引する
等の行為により外力か加わった場合にも、その外力を弾
性により吸収し、経皮端子11の破損や皮下組織7aへ
の悪影響の虞れを軽減することかできる。In addition, since the joint portion 13 is made of ceramics and materials that directly connect with the living body, it directly connects with the epidermal tissue 7b, thereby preventing the invasion of bacteria, etc., and preventing infection. . Since the terminal wood body 11a is made of a durable material, even if an external force is applied due to an action such as hitting an object or pulling it, it will absorb the external force with its elasticity and prevent damage to the percutaneous terminal 11. The possibility of adverse effects on the subcutaneous tissue 7a can be reduced.
第5図は本発明の釦3の夫hW例を示すものである。こ
の経皮端子1つは、その端子本体1. 9 aを、生体
と直接に桔合する性質を有する生体適合性セラミックス
拐料にて形成された略円筒状の連通部+4’ 20と、
同じく生体と直接に粘合する生体適合性セラミックス月
料により形或された中空孔21aを有した円板状の固定
部4A21とを、生体適合性を脊する{lit性部祠よ
り板状リング形状に形成した連粘部伺22で連結して構
成したものである。連通部材20の下部外周および固定
部伺21の内周にはこれに対応する、連結部月22の内
孔縁部と、外縁部をそれそれ嵌め込んで一体化するため
の固疋用の外周溝23と内周満24とが形成されている
。固足部+J2]の外周縁部には上記同]0
様に縫合川孔25が形成されている。FIG. 5 shows an example of the husband hW of the button 3 of the present invention. One percutaneous terminal consists of a terminal body 1. 9 a, and a substantially cylindrical communicating portion +4' 20 formed of a biocompatible ceramic material having the property of directly interlocking with a living body;
Similarly, a disk-shaped fixing part 4A21 having a hollow hole 21a formed of a biocompatible ceramic material that directly adheres to the living body is attached to the disk-shaped fixing part 4A21, which maintains biocompatibility. They are connected by a connecting part 22 formed into a shape. The lower outer periphery of the communicating member 20 and the inner periphery of the fixing part support 21 are provided with a corresponding outer periphery for fixing the inner hole edge of the connecting part 22 and the outer periphery to be fitted and integrated. A groove 23 and an inner circumference 24 are formed. A suture hole 25 is formed in the outer peripheral edge of the fixed foot part +J2 in the same manner as in the above case.
この構成の経皮端子]9は、昂5図で小ずように連通部
利20の一部を表皮組織7bから体外に突き出ず形で皮
下に埋め込み留置され、小孔25を使用し、縫合糸26
によって、皮下馴1織7aに縫合固定される。なお、連
通部伺20の連通孔27にはその使用1」的に応じて、
1壬意にカテーテル、リート線等を取り付けることかで
きる。As shown in Fig. 5, the percutaneous terminal 9 with this configuration is implanted subcutaneously with a part of the communication part 20 not protruding outside the body from the epidermal tissue 7b, and is sutured using the small hole 25. Thread 26
It is then sutured and fixed to the subcutaneous tissue 7a. In addition, the communication hole 27 of the communication part cover 20 has the following characteristics depending on its usage:
A catheter, Riet wire, etc. can be attached at will.
ここで、連通部材20は、生体と直接に粘合するセラミ
ックスH料にて形成されているため、表皮組織7bと直
接に桔合し、細菌などの侵入を防ぎ、感染を防ILする
ことかてきる。Here, since the communication member 20 is formed of a ceramic H material that directly adheres to the living body, it directly engages with the epidermal tissue 7b, prevents the invasion of bacteria, etc., and prevents infection. I'll come.
また、連通部利20、および固定部刊21は弥性部制か
らなる連結部JtA 2 2によって連話されているた
め、この経皮端子]9に外力が加わった場合にも、その
外力を連結部+4 2 2の弾性によって吸収し、皮ド
411織7aに旨たる山j状部十」としての上記固定部
月21には伝えない。In addition, since the communication part 20 and the fixed part 21 are connected by the connection part JtA 2 2 made of a flexible part, even if an external force is applied to this percutaneous terminal 9, the external force will be suppressed. It is absorbed by the elasticity of the connecting part +4 2 2 and is not transmitted to the fixed part 21 as the jagged part 10 which is effective for the skin 411 weave 7a.
さらに、この実施例では、固〉と部月21ち生体7と直
接に粘合するセラミックス+1料にて形成さ11
れているため、上述した第1、第2の尖施例のものと比
較して、生体組織との拮合性か向上しており、例えばれ
!合糸26の脱落等か発牛しても、経皮端了19の脱落
か発牛しにくい。Furthermore, in this example, since the hard part 21 is made of ceramic + 1 material that directly adheres to the living body 7, it is compared with the first and second examples described above. This has improved compatibility with living tissues, such as Re! Even if the doubling thread 26 falls off, it is difficult for the percutaneous end 19 to fall off or develop.
昂6図は本発明の第4の丈施例を示すものである。この
失地例の経皮端子30の経皮端子本体30aは、生体適
合性を有する弾性伺料からなりその略中心部に連通孔−
31を−ら′ずる連通部月32と、この連通部月32の
ド部夕{周に設けられた田板状の固定部刊33とからな
り、固定部伺33の略中心部には貫1弔川孔34か形成
され、この貫挿用孔′−34の内周縁部は上記連通部刊
32の下部外周に形成した周回満35に嵌め込まれる。Figure 6 shows the fourth length embodiment of the present invention. The percutaneous terminal main body 30a of the percutaneous terminal 30 in this example of ground loss is made of an elastic material having biocompatibility, and has a communication hole approximately in the center thereof.
31, and a plate-shaped fixed part 33 provided on the periphery of the communicating part 32. There is a penetrating part in the approximate center of the fixed part 33. A hole 34 is formed, and the inner peripheral edge of the insertion hole 34 is fitted into a circumference 35 formed on the lower outer periphery of the communication portion 32.
固定部伺33は連通部伺32の下部外周に設けられた周
同満35にはめ込むことにより固定されている。The fixing part support 33 is fixed by being fitted into a circumference 35 provided on the lower outer periphery of the communication part support 32.
また、1ti定部伺′33の上部外周には111扶の接
合部材36か彼嵌され、かつこれを気密、液密的に接j
i固走されることにより一体的に固定されている。この
接合部利36は、主体と直接に紀合する生体適合性のセ
ラミックス利料にて形或されてい12
る。Furthermore, a 111-piece connecting member 36 is fitted onto the upper outer periphery of the 1ti constant part support 33, and this is connected in an airtight and liquid-tight manner.
It is fixed integrally by being fixed. The joint 36 is formed from a biocompatible ceramic material that mates directly with the main body.
また、固定部月33の外周縁部には、縫合因定川の小孔
37か.没けられている。In addition, there is a small hole 37 for the suture in the outer periphery of the fixing part 33. It's sunken.
しかして、この経皮端子30を使用するJ45合には、
第6図て示すように接合部月36の一部を表皮組織7b
から体外に突出する形−C皮下に挫め込み、小孔37を
使用し縫含糸38によって皮下組織7aにて縫合固定す
る。なお、連通孔3]には、その使用「1的に応して作
意にカテーテル、り−1・線π5を取り{=1けること
かできる。However, in the case of J45 using this percutaneous terminal 30,
As shown in Figure 6, a part of the junction 36 is removed from the epidermal tissue 7b.
The shape-C protruding from the body is implanted under the skin, and is sutured and fixed in the subcutaneous tissue 7a using suture threads 38 using the small hole 37. Incidentally, depending on the use of the catheter, a wire of 1 and a line of π5 can be inserted into the communication hole 3.
接合部利36は、牛体7と直接に杷合するセラミックス
材料にて形或されているため、表皮組織7bと直接に拮
合することにより、細1’A ’:’jの侵入を防ぎ、
感染を防1する。Since the joint portion 36 is formed of a ceramic material that is directly joined to the cow's body 7, it prevents the intrusion of the thin part 1'A':'j by directly engaging with the epidermal tissue 7b. ,
Prevent infection.
マタ、端子本体30aの連通部+A゛32は、チ111
性材料にて形1戊されているため、経皮端子30に外力
か加わった場合にも、dlii性によりその外力を吸収
することにより、経皮端子30の破損や、皮ド組織7a
への影響か発生する危険性を軽減することかできる。The communication part +A゛32 of the terminal main body 30a is
Since the percutaneous terminal 30 is made of a flexible material, even if an external force is applied to the percutaneous terminal 30, the external force will be absorbed by the dlii property, preventing damage to the percutaneous terminal 30 and preventing damage to the skin tissue 7a.
It is possible to reduce the impact or risk of occurrence.
] 3
さらに、第3の丈施例と同様に皮下の固定部4イ33も
生体7と直接に糺合するセラミックス月ネ−■にて形成
されているため、脱落が発生しにくい。] 3 Furthermore, as in the third length embodiment, the subcutaneous fixing part 4-33 is also made of ceramic material that is directly bonded to the living body 7, so that it is less likely to fall off.
なお、」二連したように端子本体の一部に使用する+j
llt性材料は、その表面に/.I=体適含性のある伺
料をコーティングしたものでもよい。In addition, "+j" is used for a part of the terminal body like a double series.
llt property material has /. I = It may be coated with a material that is compatible with the body.
[発明の効果]
以−]二説明したように本発明によれば、表皮紹織と直
接に桔合することにより細菌の侵入や感染か発生ずるこ
とかない。さらに、外力が加えられた際に、外力を吸収
してしまうため、経皮端子自身が破損したり、生体組織
へ悪影響を与える虞れかない。[Effects of the Invention] As explained above, according to the present invention, there is no possibility of bacterial invasion or infection due to direct engagement with the epidermal tissue. Furthermore, since the external force is absorbed when an external force is applied, there is no risk that the percutaneous terminal itself will be damaged or that it will have an adverse effect on living tissue.
示し、珀1図はその皮下端子の側断面図、第2図はその
皮下端子の使用状悪の側断面図、沁3図はその皮下端−
r−における固走部イイの平面図、第4図は本発明のゴ
52の失施例を示すその皮下端子の使用状悪の側断面図
、昂5図は本発明の第3の丈施] 4
例を示すその皮下端了の使用状態の側断rfj A4、
第6図は本発明の第4の実施例を示すその皮1・゛端子
の使用状悪の側断面図である。Figure 1 is a side sectional view of the subcutaneous terminal, Figure 2 is a side sectional view of the subcutaneous terminal in poor use, and Figure 3 is a side sectional view of the subcutaneous terminal.
Fig. 4 is a side sectional view of the subcutaneous terminal in poor use condition showing an example of failure of the go 52 of the present invention; ]4 Side section RFJ A4 of the usage state of its subcutaneous end showing an example,
FIG. 6 is a side sectional view of a fourth embodiment of the present invention, showing a skin terminal in poor use.
] ・皮下端子、]a・皮下端子本体、2連通部刊、3
・・・固定部刊、7・牛体、7a皮下組織、7b・・表
皮組織、1]・・皮下端子、1. 1 a・端子本体、
13・ 接合部刊、]9皮下端子、20 ・連通部刊、
2] ・固足部刊、22・連結部十4、30・皮下端子
、30a’・皮下端子本体、32・・・連通部利、33
・・・固足部利、36・接合部利。]・Subcutaneous terminal, ]a・Subcutaneous terminal body, Published by 2nd Communication Department, 3
... Fixed Department publication, 7. Bovine body, 7a. Subcutaneous tissue, 7b.. Epidermal tissue, 1].. Subcutaneous terminal, 1. 1 a. Terminal body,
13. Published by Junction Department,] 9 Subcutaneous terminal, 20. Published by Communication Department,
2] - Published by Kosakubu, 22 - Connection part 14, 30 - Subcutaneous terminal, 30a' - Subcutaneous terminal body, 32... Communication part 14, 33
... solid foot part profit, 36. joint part profit.
Claims (1)
せた形で生体内に埋込み留置される経皮端子において、
この端子本体は、少なくとも生体の表皮組織と接合する
接合部分を生体適合性セラミックス材料で形成し、上記
表皮組織との接合する部位以外で、生体内に埋め込み留
置される部分に皮下組織に当たる面状部を設け、上記面
状部、またはその面状部と上記接合部分との間を連結す
る部分の少なくとも一方を弾性材料にて形成したことを
ことを特徴とする経皮端子。In a percutaneous terminal that is implanted in a living body through the epidermal tissue of the living body with a part of the terminal main body protruding outside the body,
This terminal main body has at least the joint part that joins with the epidermal tissue of the living body made of a biocompatible ceramic material, and the part that is implanted and indwelled in the living body has a surface that contacts the subcutaneous tissue other than the part that joins with the epidermal tissue. A percutaneous terminal, wherein at least one of the planar portion or a portion connecting the planar portion and the joint portion is made of an elastic material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1157152A JPH0323868A (en) | 1989-06-20 | 1989-06-20 | Percataneous terminal |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1157152A JPH0323868A (en) | 1989-06-20 | 1989-06-20 | Percataneous terminal |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0323868A true JPH0323868A (en) | 1991-01-31 |
Family
ID=15643316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1157152A Pending JPH0323868A (en) | 1989-06-20 | 1989-06-20 | Percataneous terminal |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0323868A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018510748A (en) * | 2015-03-26 | 2018-04-19 | サーモディクス,インコーポレイテッド | Controlled release matrix barrier structure for subcutaneous medical devices |
WO2023210795A1 (en) * | 2022-04-28 | 2023-11-02 | 株式会社ハイレックスコーポレーション | Fixing structure |
WO2023210794A1 (en) * | 2022-04-28 | 2023-11-02 | 株式会社ハイレックスコーポレーション | Fixing structure |
-
1989
- 1989-06-20 JP JP1157152A patent/JPH0323868A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018510748A (en) * | 2015-03-26 | 2018-04-19 | サーモディクス,インコーポレイテッド | Controlled release matrix barrier structure for subcutaneous medical devices |
WO2023210795A1 (en) * | 2022-04-28 | 2023-11-02 | 株式会社ハイレックスコーポレーション | Fixing structure |
WO2023210794A1 (en) * | 2022-04-28 | 2023-11-02 | 株式会社ハイレックスコーポレーション | Fixing structure |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Grosse‐Siestrup et al. | Design criteria for percutaneous devices | |
US3402710A (en) | Self-closing valve device for implantation in the human body | |
US20070060891A1 (en) | Implant with a skin penetration section | |
US5971962A (en) | Skin button | |
JPH04307068A (en) | Catheter for endarmic transplantation | |
US4959054A (en) | Pharmaceutically protected percutaneous devices | |
RU2561864C2 (en) | Prosthesis of orthotopic artificial urinary bladder | |
US5425639A (en) | Dental implant with shock absorbent cushioned interface | |
US7083648B2 (en) | Tissue lockable connecting structures | |
US10835392B2 (en) | Transdermal intraosseous device | |
US3646616A (en) | Prosthesis for implanting around a body duct such as the urethra and method of treating urinary incontinence | |
US9320840B2 (en) | Catheter vacuum dressing apparatus and methods of use | |
NZ334489A (en) | Coated prosthetic cardiac device | |
ATE300256T1 (en) | SUBCUTANEOUS, INTRAMUSCULAR BEARING FOR A RIGID TRANSCUTANE IMPLANT | |
US20140039617A1 (en) | Breast Implant Assembly | |
US4728331A (en) | Endo-extracorporeal implant and fibro-inductive and/or osteo-inductive seal therefor | |
US5061280A (en) | Ossicular prosthesis | |
JP2005501668A (en) | Transcutaneous access device | |
ATE373453T1 (en) | STENT AND APPLICATOR | |
EP0667131A3 (en) | Percutaneous implantable endoprothesin in the body of a patient. | |
WO2005013855A3 (en) | Implant delivery device | |
WO2001080921A3 (en) | Native protein mimetic fibers, fiber networks and fabrics for medical use | |
JPH0323868A (en) | Percataneous terminal | |
US20010004714A1 (en) | Implant holder | |
JP6159041B1 (en) | Artificial valve |